RATG is named as an intervention in 2 current clinical trials in our France and Italy registers. 1 is recruiting patients now. The most common phase is Phase 3. The sponsor with the most trials is University Hospital, Tours (1). The most-studied condition is Renal Transplant Rejection.
| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
Induction in Sensitized Kidney Transplant Recipients Without Pre-existing Donor-specific antiboDies
NCT05385432 · ClinicalTrials.gov ↗ · Renal Transplant Rejection, Induction Therapy
|
Phase 3 | Recruiting | University Hospital, Tours | France |
|
1 vs 7 RATG Infusions in Renal Transplantation
NCT06374095 · ClinicalTrials.gov ↗ · Kidney Replacement
|
Observational | Active, closed | Mario Negri Institute for Pharmacological Research | Italy |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Lead sponsor | Trials |
|---|---|
| University Hospital, Tours | 1 |
| Mario Negri Institute for Pharmacological Research | 1 |
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in France | 1 | 1 |
| Clinical trials in Italy | 1 | 0 |
A trial with sites in more than one country appears in each of those registers.
2 current trials in our France and Italy registers name RATG as a drug or biological intervention, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.
Yes. 1 of the 2 trials is recruiting: 1 with sites in France. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
University Hospital, Tours (1) and Mario Negri Institute for Pharmacological Research (1). The number in brackets is how many trials each organisation leads.
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how RATG works or whether it is effective, and it is not medical advice.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how RATG works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists RATG (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 26 Sep 2026.